CORONA2,200.00

CORONA Remedies Ltd.

· Pharma & Health
₹ CrorePeersERISMANKINDAPLLTDALIVUSAKUMSAGARWALEYEHCGADVENZYMESMcap ₹13,455 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment291.1291.1
+ Capital Work-in-Progress143.1143.1
+ Other Intangibles262.8262.8
+ Investments (Equity Method)26.126.1
+ Non-current Investments0.20.2
+ Long-term Loans0.00.0
+ Other Non-current Financial Assets129.9129.9
Non-current Financial Assets130.1130.1
+ Other Non-current Assets3.63.6
Total Non-current Assets856.8856.8
Current Assets
+ Inventories125.0125.0
+ Trade Receivables145.6145.6
+ Cash & Cash Equivalents1.81.8
+ Other Bank Balances42.342.3
+ Short-term Loans0.30.3
+ Other Current Financial Assets0.30.3
Current Financial Assets190.2190.2
+ Other Current Assets33.133.1
Total Current Assets348.3348.3
Total Assets1,205.11,205.1
Equity
+ Equity Share Capital61.261.2
+ Other Equity / Reserves685.7685.7
Equity — Owners of Parent746.9746.9
Total Equity746.9746.9
Liabilities
+ Other Non-current Financial Liab18.918.9
Non-current Financial Liabilities18.918.9
+ Provisions — Non-current66.166.1
+ Deferred Tax Liabilities12.212.2
Non-current Liabilities97.197.1
+ Borrowings — Current142.9142.9
+ Trade Payables147.1147.1
+ Other Current Financial Liab22.822.8
Current Financial Liabilities312.8312.8
+ Provisions — Current33.033.0
+ Current Tax Liabilities8.48.4
+ Other Current Liabilities7.07.0
Current Liabilities361.2361.2
Total Liabilities458.3458.3
Total Equity & Liabilities1,205.11,205.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current9.99.9
+ Dues to Other Creditors — Current137.2137.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.